Navigation Links
Infection data may not be comparable across hospitals, study shows
Date:9/18/2012

A new study has found that some kinds of infection data may not be comparable across hospitals, and may not be suitable for use as a performance measure.

Published in the leading US policy journal Milbank Quarterly, the research found huge variability in how English hospitals collected, recorded and reported their rates of central line infections to a patient safety programme. The study was funded by the Health Foundation, a major UK charitable foundation aiming to improve quality of care.

"Central line infections occur in tubes used in treating seriously ill patients. These infections are largely preventable, and hospitals need to be able to monitor how well they are doing in controlling them," said study author Professor Mary Dixon-Woods from University of Leicester. "But because hospitals don't use the same methods to generate the data, using their reported rates to produce league tables of performance or to impose financial sanctions, as happens in the US, is probably not appropriate."

Researchers found most variability arose for what they called "mundane" reasons. These included challenges in setting up data collection systems, different practices in sending blood samples for analysis, and difficulties in deciding the source of infections.

"Although hospitals were given clear, standardised definitions to use, many laboratories did not have the tools to make the most definitive assessment of where infections were coming from in the patient's body," said Julian Bion, Professor of Intensive Care Medicine at University of Birmingham. "That meant they had to use clinical judgement to decide whether any infection was due to a central line. Once you are relying on judgement, you will get variation."

The study dismissed 'gaming' as the explanation for the variations the researchers found. "Some previous studies have reported deliberate manipulation of performance data to 'look good'", said Professor Dixon-Woods. "We found very little evidence of this. We did find that doctors were fine with making a clinical decision that a patient might have a central line infection for purposes of treating them, but they wanted better evidence if they were going to report an infection externally. That meant that sometimes a patient who was treated as having an infection while in hospital was not counted as having an infection when data were reported. Doctors also varied in how many blood samples they sent off for laboratory analysis".

Professor Bion commented that these findings have important lessons for those involved in improving the quality of patient care. He said: "The study shows that if we are going to use data produced by hospitals to guide quality improvement, data collection systems must be carefully designed and operated, fully integrated with clinical priorities, and impose minimum burden. We need data that clinicians and organizations believe in. And until we have that, we need to be very careful about comparing performance across hospitals. We certainly need to avoid basing pay-for-performance schemes on central line data, because it's now becoming clear that these schemes have many unintended consequences."

Dr Elaine Maxwell, Assistant Director at the Health Foundation, commented: " This research highlights the very real difficulties in measuring safety in healthcare. Adverse events such as infections are increasingly being used in performance management. This study demonstrates that accurate data collection is more complex than may have at first been imagined. The Health Foundation is continuing to support the development of reliable and sensitive safety measures to reflect sustained improvement."


'/>"/>

Contact: Professor Mary Dixon-Woods
md11@le.ac.uk
44-011-622-97262
University of Leicester
Source:Eurekalert  

Related medicine news :

1. Infection Might Raise Blood Clot Risk for Older Adults: Study
2. Junk DNA can sense viral infection
3. Pacemakers, Defibrillators Sources of Deadly Infections: Study
4. Children with juvenile arthritis have higher rates of bacterial infection
5. Arthritis in Children Linked to Infections
6. Study confirms early elevated HIV infection risk in some Step Study participants
7. Scripps Research scientists show how memory B cells stay in class to fight different infections
8. Infection Causes 1 in 6 Cancers Worldwide: Study
9. Living longer - variability in infection-fighting genes can be a boon for male survival
10. FDA Advisers Back Pill to Help Prevent HIV Infection
11. University of Minnesota startup to treat challenging bacterial infection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Infection data may not be comparable across hospitals, study shows
(Date:12/8/2016)... Fort Myers, FL (PRWEB) , ... December 08, 2016 , ... ... that serves business owners and families in and around the Cape Coral area, is ... the Harry Chapin Food Bank of Southwest Florida. , The Harry Chapin Food Bank ...
(Date:12/8/2016)... KS (PRWEB) , ... December 08, 2016 , ... ... financial consultation services to families and business owners in and around central Kansas, ... provide assistance to at-risk youth in the region. , Headquartered in Wichita, Youth ...
(Date:12/7/2016)... VA (PRWEB) , ... December 07, 2016 , ... ... are celebrating the passage of the most comprehensive mental health systems reform legislation ... the support of the President, and the commitment of our elected officials to ...
(Date:12/7/2016)... ... December 07, 2016 , ... Silhouette Instalift is a ... smoothing and tightening the skin of the face to create more youthful features. ... with very little downtime, Silhouette Instalift is a novel, minimally invasive facial procedure ...
(Date:12/7/2016)... ... December 07, 2016 , ... EnghouseSystems ... purchase price of approximately $17.4 million (net of the cash acquired), subject ... $13.2 million. Headquartered in Barcelona, Spain, Presence is a leading provider of ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... FALLS, N.J., Dec. 8, 2016 CANTEL MEDICAL CORP. ... income of $18,800,000, or $0.45 per diluted share, on a ... first quarter ended October 31, 2016. This compares with net ... of $153,779,000 for the first quarter ended October 31, 2015. ... first quarter ended October 31, 2016 to $21,323,000, or $0.51 ...
(Date:12/8/2016)... , Dec. 8, 2016   Mederi Therapeutics Inc . has announced regulatory ... Therapy, a non-surgical treatment for chronic gastroesophageal reflux disease (GERD). ... ... and broadcast during the Chinese Congress of Digestive Endoscopy, by Professor Jun Liu, Director ... , , "We are very ...
(Date:12/8/2016)... BEIJING , and SAN DIEGO , ... genomic services and solutions with cutting edge next-generation sequencing and ... biotechnology company; and the Genome Institute of ... (NovogeneAIT) – a new joint venture between Novogene and AITbiotech ... at Biopolis, Singapore .   ...
Breaking Medicine Technology: